LexaGene Successfully Completes CRADA with US Army : vimarsa

BEVERLY, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

Related Keywords

Randy Hofmann , Jack Regan , Development Agreement , Excet Inc , Technical Group Leader , Program Executive Office For Chemical , Lexagene Holdings Inc , Chemical Biological Center , Nuclear Defense , Us Army , Gene Holdings , Biological Center , Cooperative Research , Joint Program Executive Office , Joint Project Lead , Defense Biological Product Assurance Office , Tsx Venture Exchange Lxg ,